These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10976947)

  • 21. Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.
    Verma V; Hasbi A; O'Dowd BF; George SR
    J Biol Chem; 2010 Nov; 285(45):35092-103. PubMed ID: 20807772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dopaminergic agents on carrageenan hyperalgesia in rats.
    Gao X; Zhang Y; Wu G
    Eur J Pharmacol; 2000 Oct; 406(1):53-8. PubMed ID: 11011033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells.
    Sakolsky DJ; Ashby B
    Recept Channels; 2001; 7(6):479-89. PubMed ID: 11918350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D1 dopamine receptor activity of anti-parkinsonian drugs.
    Fici GJ; Wu H; VonVoigtlander PF; Sethy VH
    Life Sci; 1997; 60(18):1597-603. PubMed ID: 9126882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK
    Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.
    Perreault ML; Shen MY; Fan T; George SR
    Neuroscience; 2015 Jan; 285():194-203. PubMed ID: 25446350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats.
    Gao X; Zhang Y; Wu G
    Eur J Pharmacol; 2001 Apr; 418(1-2):73-7. PubMed ID: 11334867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex.
    Vincent SL; Khan Y; Benes FM
    J Neurosci; 1993 Jun; 13(6):2551-64. PubMed ID: 8501521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine receptor-mediated regulation of expression of Fos and its related antigens (FRA) in somatostatin neurons in the hypothalamic periventricular nucleus.
    Cheung S; Johnson JD; Moore KE; Lookingland KJ
    Brain Res; 1997 Oct; 770(1-2):176-83. PubMed ID: 9372217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
    Ng GY; George SR
    Eur J Pharmacol; 1994 Nov; 269(3):365-74. PubMed ID: 7895775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
    Chu J; Wilczynski W; Wilcox RE
    Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus.
    Rossato JI; Radiske A; Kohler CA; Gonzalez C; Bevilaqua LR; Medina JH; Cammarota M
    Neurobiol Learn Mem; 2013 Nov; 106():66-70. PubMed ID: 23891712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the intravitreal administration of dopaminergic ligands on the b-wave amplitude of the rabbit electroretinogram.
    Huppé-Gourgues F; Coudé G; Lachapelle P; Casanova C
    Vision Res; 2005 Jan; 45(2):137-45. PubMed ID: 15581915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of (-)-stepholidine and D1 or D2 agonists on unit firing of globus pallidus in 6-hydroxydopamine-lesioned rats.
    Zhang XX; Zhu ZT; Jin GZ
    Life Sci; 1998; 63(7):537-44. PubMed ID: 9718079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.